Skip to main content
NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
PA

Phibro Animal Health Corporation (PAHC)

NASDAQ • Healthcare

$36.79
-$0.51 (-1.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$37.11
Previous Close$36.8
Day Range$36.6 - $37.46
Avg. Volume (3M)228.8K
Market Cap$1.4B
P/E Ratio15.0
52 Week Range
$28.25$60.08
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$396.7M100%
Gross Profitminus cost of goods$134.4M34%
Operating Incomeminus R&D and overhead$48.1M12%
Net Incomeminus taxes and the rest$21.7M5%

In plain terms: out of every $100 in revenue, Phibro Animal Health Corporation keeps $5 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.5B
Net Income (TTM)
$99.7M
EPS (TTM)
$2.46
ROA (TTM)
6.64%
Current Ratio
2.96
Dividend Yield
0.38%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+26.1%Q1 2026$0.87
+5.6%Q2 2026$0.76
+19.2%Q3 2026$0.85
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +19.2%

Phibro Animal Health beat expectations on both the top and bottom line in the fourth fiscal quarter of 2026, based on preliminary results reported August 26, 2026, with adjusted EPS of $0.85 topping the $0.71 estimate (+19%) and revenue of $396.7 million topping the $381.2 million estimate (+4.1%). Revenue rose ~5% to about $396.7 million from roughly $378.7 million a year ago, with the business spanning Animal Health, Mineral Nutrition, and Performance Products. Profitability metrics were reported at a gross margin of roughly 36% and an operating margin of about 11%, alongside gross profit of about $141.4 million and operating income of roughly $44.1 million. Net income increased ~26% year over year to about $21.7 million, up from roughly $17.2 million a year ago. Consensus for the next period calls for EPS of $0.79 on revenue of $376.0 million.

View full earnings history

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a NASDAQ-listed healthcare company that develops, makes, and sells animal health and related specialty products, with $1.3 billion in FY2025 revenue. Its business spans pharmaceuticals, biologics, mineral nutrition, and specialty ingredients used in livestock production and selected non-animal end markets.

Name
Phibro Animal Health Corporation
CEO
Daniel Bendheim
Website
www.pahc.com
Industry
Healthcare
Year Founded
2014
Employees
2,605

Today's Snapshot

AI-generated

So far today, PAHC is trading slightly lower at 36.65, in line with a flat sector.

Trading Volume

Below 10d avg (260.9K)

52.2K

vs S&P 500 Today

Moderate Outperformance

+0.16%

Updated: September 10, 2026 at 17:05 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
PAHC registers a sell bias driven by its position relative to key averages and mixed volume cues despite some trend strength. ADX is elevated, suggesting a more established directional move, yet price sits below several short- and long-term moving averages including the 200-day, with nearby VWAP and pivot marginally above the market. Momentum measures are largely neutral and MACD is flat, while ATR shows moderate volatility. The volume picture is mixed—OBV is negative in absolute terms despite a buy annotation—leaving momentum weak against overhead averages. Technical takeaway: sell — pressure from moving-average resistance within a higher-volatility environment.
All signals
  • EMA (5 indicators)$36.12 - $39.96
    Sell
  • RSI (14)50.99
    Neutral
  • Stochastic %K (14, 3, 3)36.11
    Neutral
  • MACD Level (12, 26)0.73
    Neutral

Peers & Related Assets

OGNOrganon & Co.
$13.67-0.6%
MDPediatrix Medical Group, Inc.
$27.09+0.6%
AUPHAurinia Pharmaceuticals Inc.
$16.25+1.1%
ANIPANI Pharmaceuticals, Inc.
$70.7+0.7%
MNKDMannKind Corporation
$3.94-5.3%
TLRYTilray Brands, Inc.
$4.16-1.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.